The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Willmar Schwabe Award 2006: Antiplasmodial and Antitumor Activity of Artemisinin - From Bench to Bedside
Open accessAbstract
Secondary metabolites from plants serve as defense against herbivores, microbes, viruses, or competing plants. Many medicinal plants have pharmacological activities and may, thus, be a source for novel treatment strategies. During the past 10 years, we have systematically analyzed medicinal plants used in traditional Chinese medicine and focused our interest on Artemisia annua L. (qinhao, sweet wormwood). We found that the active principle of Artemisia annua L., artemisinin, exerts not only antimalarial activity but also profound cytotoxicity against tumor cells. The inhibitory activity of artemisinin and its derivatives towards cancer cells is in the nano- to micromolar range. Candidate genes that may contribute to the sensitivity and resistance of tumor cells to artemisinins were identified by pharmacogenomic and molecular pharmacological approaches. Target validation was performed using cell lines transfected with candidate genes or corresponding knockout cells. The identified genes are from classes with diverse biological functions; for example, regulation of proliferation (BUB3, cyclins, CDC25A), angiogenesis (vascular endothelial growth factor and its receptor, matrix metalloproteinase-9, angiostatin, thrombospondin-1) or apoptosis (BCL-2, BAX, NF-kappaB). Artesunate triggers apoptosis both by p53-dependent and -independent pathways. Antioxidant stress genes (thioredoxin, catalase, gamma-glutamylcysteine synthetase, glutathione S-transferases) as well as the epidermal growth factor receptor confer resistance to artesunate. Cell lines overexpressing genes that confer resistance to established antitumor drugs (MDR1, MRP1, BCRP, dihydrofolate reductase, ribonucleotide reductase) were not cross-resistant to artesunate, indicating that artesunate is not involved in multidrug resistance. The anticancer activity of artesunate has also been shown in human xenograft tumors in mice. First encouraging experience in the clinical treatment of patients suffering from uveal melanoma calls for comprehensive clinical trials with artesunate for cancer treatment in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., et al. (2006) · Nature · doi:10.1038/nature04640 · Cited by 2,805
Engineering a mevalonate pathway in Escherichia coli for production of terpenoids
Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D., & Keasling, J. D. (2003) · Nature Biotechnology · doi:10.1038/nbt833 · Cited by 1,725
Clinical translation of angiogenesis inhibitors
Kerbel, R., & Folkman, J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc905 · Cited by 1,517
The role of angiogenesis in tumor growth.
Folkman, J. (1992) · PubMed · Cited by 1,259
White, N. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421682 · Cited by 1,248
World Health Organization (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90300-6 · Cited by 1,085
Artemisinins target the SERCA of Plasmodium falciparum
Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027
Sutherland, R., Delia, D., Schneider, C., Newman, R., Kemshead, J., & Greaves, M. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4515 · Cited by 685
The anti-malarial artesunate is also active against cancer
Efferth, T., Dunstan, H., Sauerbrey, A., Miyachi, H., & Chitambar, C. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.4.767 · Cited by 564
Self-citationApoptosis defects and chemotherapy resistance: molecular interaction maps and networks
Pommier, Y., Sordet, O., Antony, S., Hayward, R. L., & Kohn, K. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207515 · Cited by 560
Artesunate combinations for treatment of malaria: meta-analysis
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15162-8 · Cited by 538
Transferrin receptors in human tissues: their distribution and possible clinical relevance.
Gatter, K. C., Brown, G., Trowbridge, I. S., Woolston, R. E., & Mason, D. Y. (1983) · Journal of Clinical Pathology · doi:10.1136/jcp.36.5.539 · Cited by 531
Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy
Baselga, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-2004-2 · Cited by 510
Antimalarial drug resistance and combination chemotherapy
White, N. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0426 · Cited by 477
Effects of artemisinin derivatives on malaria transmissibility
Price, R. N., Nosten, F., Luxemburger, C., ter Kuile, F. O., Paiphun, L., Price, R. N., Luxemburger, C., Chongsuphajaisiddhi, T., White, N. J., Price, R. N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91488-9 · Cited by 462
The translationally controlled tumour protein (TCTP)
Bommer, U.-A., & Thiele, B.-J. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00213-9 · Cited by 447
Molecular Modes of Action of Artesunate in Tumor Cell Lines
Efferth, T., Sauerbrey, A., Olbrich, A., Gebhart, E., Rauch, P., Weber, H. O., Hengstler, J. G., Halatsch, M.-E., Volm, M., Tew, K. D., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.382 · Cited by 428
Self-citationMutabingwa, T. K. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.06.009 · Cited by 352
Schmid, G., & Hofheinz, W. (1983) · Journal of the American Chemical Society · doi:10.1021/ja00341a054 · Cited by 329
Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu)
Meshnick, S. R., Yang, Y. Z., Lima, V, Kuypers, F., Kamchonwongpaisan, S., & Yuthavong, Y. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1108 · Cited by 327
Gachet, Y., Tournier, S., Lee, M., Lazaris-Karatzas, A., Poulton, T., & Bommer, U.-A. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.8.1257 · Cited by 288
Cytotoxicity of Artemisinin-Related Endoperoxides to Ehrlich Ascites Tumor Cells
Woerdenbag, H. J., Moskal, T. A., Pras, N., Malingré, T. M., El-Feraly, F. S., Kampinga, H. H., & Konings, A. W. T. (1993) · Journal of Natural Products · doi:10.1021/np50096a007 · Cited by 278
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron
Efferth, T., Benakis, A., Romero, M. R., Tomicic, M., Rauh, R., Steinbach, D., Häfer, R., Stamminger, T., Oesch, F., Kaina, B., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.023 · Cited by 266
Self-citationMolecular Pharmacology and Pharmacogenomics of Artemisinin and its Derivatives in Cancer Cells
Efferth, T. (2006) · Current Drug Targets · doi:10.2174/138945006776359412 · Cited by 262
Self-citationA single amino acid residue can determine the sensitivity of SERCAs to artemisinins
Uhlemann, A.-C., Cameron, A., Eckstein-Ludwig, U., Fischbarg, J., Iserovich, P., Zuniga, F. A., East, M., Lee, A., Brady, L., Haynes, R. K., et al. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb947 · Cited by 256
Artemisinin, a Novel Antimalarial Drug: Biochemical and Molecular Approaches for Enhanced Production
Abdin, M. Z., Israr, M., Rehman, R. U., & Jain, S. K. (2003) · Planta Medica · doi:10.1055/s-2003-38871 · Cited by 252
Artemisinins: mechanisms of action and potential for resistance
KRISHNA, S., UHLEMANN, A., & HAYNES, R. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.07.001 · Cited by 243
Reaction of antimalarial endoperoxides with specific parasite proteins
Asawamahasakda, W., Ittarat, I., Pu, Y. M., Ziffer, H., & Meshnick, S. R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1854 · Cited by 234
Romero, M. R., Efferth, T., Serrano, M. A., Castaño, B., Macias, R. I. R., Briz, O., & Marin, J. J. G. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.07.005 · Cited by 233
Self-citationDell’Eva, R., Pfeffer, U., Vené, R., Anfosso, L., Forlani, A., Albini, A., & Efferth, T. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.08.021 · Cited by 230
Self-citationEfferth, T., Davey, M., Olbrich, A., Rücker, G., Gebhart, E., & Davey, R. (2002) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2002.0492 · Cited by 223
Self-citationChen, H. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00107-5 · Cited by 219
Artemisinin induces apoptosis in human cancer cells.
Singh, N. P., & Lai, H. C. (2004) · PubMed · Cited by 218
Bertea, C. M., Freije, J. R., van der Woude, H., Verstappen, F. W., Perk, L., Marquez, V., De Kraker, J.-W., Posthumus, M. A., Jansen, B. J., de Groot, A., et al. (2005) · Planta Medica · doi:10.1055/s-2005-837749 · Cited by 205
YEUNG, S., PONGTAVORNPINYO, W., HASTINGS, I. M., MILLS, A. J., & WHITE, N. J. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.179 · Cited by 197
Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin
Lai, H., & Singh, N. P. (1995) · Cancer Letters · doi:10.1016/0304-3835(94)03716-v · Cited by 183
Efferth, T., Marschall, M., Wang, X., Huong, S.-M., Hauber, I., Olbrich, A., Kronschnabl, M., Stamminger, T., & Huang, E.-S. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-001-0300-8 · Cited by 182
Self-citationDelabays, N., Simonnet, X., & Gaudin, M. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013371635 · Cited by 178
Artesunate in the treatment of metastatic uveal melanoma - first experiences
Berger, T., Dieckmann, D., Efferth, T., Schultz, E., Funk, J.-O., Baur, A., & Schuler, G. (2005) · Oncology Reports · doi:10.3892/or.14.6.1599 · Cited by 176
Self-citationLai, H., & Singh, N. P. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.01.019 · Cited by 170
Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy
EFFERTH, T. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.04.003 · Cited by 169
Self-citationFu, Y., Zu, Y., Liu, W., Efferth, T., Zhang, N., Liu, X., & Kong, Y. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.08.067 · Cited by 163
Self-citationArtemisinin‐based combination therapies for uncomplicated malaria
Davis, T. M. E., Karunajeewa, H., & Ilett, K. F. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb06650.x · Cited by 156
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo
Kaptein, S. J. F., Efferth, T., Leis, M., Rechter, S., Auerochs, S., Kalmer, M., Bruggeman, C. A., Vink, C., Stamminger, T., & Marschall, M. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.10.003 · Cited by 155
Self-citationPharmacogenetics for individualized cancer chemotherapy
Efferth, T., & Volm, M. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.02.005 · Cited by 153
Self-citationArtemisinin inhibits inducible nitric oxide synthase and nuclear factor NF‐kB activation
Aldieri, E., Atragene, D., Bergandi, L., Riganti, C., Costamagna, C., Bosìa, A., & Ghigo, D. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00905-0 · Cited by 153
Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials.
Ribeiro, I. R., & Olliaro, P. (1998) · PubMed · Cited by 144
Artemisinin and derivatives: the future for malaria treatment?
Haynes, R. K. (2001) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200112000-00010 · Cited by 141
Chen, H., Zhou, H., Wu, G.-D., & Lou, X.-E. (2004) · Pharmacology · doi:10.1159/000076256 · Cited by 135
Efferth, T., Olbrich, A., & Bauer, R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01221-2 · Cited by 134
Self-citationTetraploid Artemisia annua hairy roots produce more artemisinin than diploids
Jesus-Gonzalez, L. D., & Weathers, P. J. (2003) · Plant Cell Reports · doi:10.1007/s00299-003-0587-8 · Cited by 133
Time to put malaria control on the global agenda
Butler, D., Maurice, J., & O’Brien, C. (1997) · Nature · doi:10.1038/386535a0 · Cited by 131
Artemisinin Enhances Heme-Catalysed Oxidation of Lipid Membranes
Berman, P. A., & Adams, P. A. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00508-4 · Cited by 131
Antimalarial Synergy of Cysteine and Aspartic Protease Inhibitors
Semenov, A., Olson, J. E., & Rosenthal, P. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2254 · Cited by 131
Li, W., Dong, Y.-J., Tu, Y., & Lin, Z. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.004 · Cited by 130
Anfosso, L., Efferth, T., Albini, A., & Pfeffer, U. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500371 · Cited by 127
Self-citationAntimalarial dihydroartemisinin also inhibits angiogenesis
Chen, H., Zhou, H., Wang, W., & Wu, G. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0751-4 · Cited by 125
Moore, J. C., Lai, H. C., Li, J.-R., Ren, R., McDougall, J. A., Singh, N. P., & Chou, C. (1995) · Cancer Letters · doi:10.1016/s0304-3835(06)80014-5 · Cited by 122
Stereochemistry-Dependent Cytotoxicity of Some Artemisinin Derivatives
Beekman, A. C., Barentsen, A. R. W., Woerdenbag, H. J., van Uden, W., Pras, N., Konings, A. W. T., El‐Feraly, F. S., Galal, A. M., & Wikström, H. (1997) · Journal of Natural Products · doi:10.1021/np9605495 · Cited by 118
Effects of artemisinin-tagged holotransferrin on cancer cells
Lai, H. C., Sasaki, T., Singh, N. P., & Messay, A. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.08.020 · Cited by 107
Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs.
Efferth, T., Rüċker, G., Falkenberg, M. B., Manns, D., Olbrich, A., Fabry, U., & Osieka, R. (1996) · PubMed · Cited by 105
Self-citationStereoselective synthesis of artemisinin
Ravindranathan, T., Anil Kumar, M., Menon, R. B., & Hiremath, S. V. (1990) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)94621-5 · Cited by 103
Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells
Sadava, D., Phillips, T., Lin, C., & Kane, S. E. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00005-8 · Cited by 100
Molecular modes of action of cantharidin in tumor cells
Efferth, T., Rauh, R., Kahl, S., Tomicic, M. T., Böchzelt, H., Tome, M. E., Briehl, M. M., Bauer, R., & Kaina, B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.12.003 · Cited by 99
Self-citationProduction of artemisinin in tissue cultures of Artemisia annua
Nair, M. S. R., Acton, N., Klayman, D. L., Kendrick, K., Basile, D. V., & Mante, S. (1986) · Journal of Natural Products · doi:10.1021/np50045a021 · Cited by 98
Butler, A. R., Gilbert, B. C., Hulme, P., Irvine, L. R., Renton, L. F., & Whitwood, A. C. (1998) · Free Radical Research · doi:10.3109/10715769809066884 · Cited by 94
Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle
Li, Y., Shan, F., Wu, J., Wu, G., Ding, J., Xiao, D., Yang, W., Atassi, G., Léonce, S., Caignard, D., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00578-3 · Cited by 89
Role of antioxidant genes for the activity of artesunate against tumor cells
Efferth, T., Briehl, M. M., & Tome, M. E. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.4.1231 · Cited by 88
Self-citationAgricultural production of artemisinin—a review
Laughlin, J. C. (1994) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(94)90465-0 · Cited by 87
Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes.
Lotem, J., & Sachs, L. (1996) · PubMed · Cited by 86
Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives
Ke, O., Krug, E. C., Marr, J. J., & Berens, R. L. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.10.1961 · Cited by 85
Efferth, T., Ramírez, T., Gebhart, E., & Halatsch, M. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.035 · Cited by 83
Self-citationCancer Anti-angiogenic Therapy
Shimizu, K., & Oku, N. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.599 · Cited by 83
Shterman, N., Kupfer, B., & Moroz, C. (2008) · Pathobiology · doi:10.1159/000163611 · Cited by 81
Efferth, T., & Volm, M. (2005) · PubMed · Cited by 68
Self-citationDifferentially expressed genes in C6.9 glioma cells during vitamin D-induced cell death program
Baudet, C., Perret, E., Delpech, B., Kaghad, M., Brachet, P., Wion, D., & Caput, D. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400327 · Cited by 67
Tang, W., Hemm, I., & Bertram, B. (2003) · Planta Medica · doi:10.1055/s-2003-38494 · Cited by 66
Tang, W., Hemm, I., & Bertram, B. (2003) · Planta Medica · doi:10.1055/s-2003-37718 · Cited by 62
Yichong, L., & Yl, W. (1998) · PubMed · Cited by 59
Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients.
Volm, M., Koomägi, R., Mattern, J., & Efferth, T. (2002) · PubMed · Cited by 59
Self-citationApoptosis and resistance to daunorubicin in human leukemic cells
Efferth, T., Fabry, U., & Osieka, R. (1997) · Leukemia · doi:10.1038/sj.leu.2400669 · Cited by 58
Self-citationArtemisinin: an alternative treatment for oral squamous cell carcinoma.
Yamachika, E., Habte, T., & Oda, D. (2004) · PubMed · Cited by 48
Adjuvant therapy in cerebral malaria.
Mohanty, S., Patel, D. K., Pati, S. S., & Mishra, S. K. (2006) · PubMed · Cited by 47
Parapini, S., Basilico, N., Mondani, M., Olliaro, P., Taramelli, D., & Monti, D. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.08.039 · Cited by 42
Susceptibility of Pneumocystis carinii to artemisinin in vitro
Merali, S., & Meshnick, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1225 · Cited by 42
Efferth, T., & Volm, M. (1993) · Cancer Letters · doi:10.1016/0304-3835(93)90231-w · Cited by 42
Self-citationThe herbal tea approach for artemisinin as a therapy for malaria?
Jansen, F. H. (2005) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.08.004 · Cited by 34
Microbial Transformation Studies on Arteannuin B
Elmarakby, S. A., El‐Feraly, F. S., ElSohly, H. N., et al. (1987) · Journal of Natural Products · doi:10.1021/np50053a022 · Cited by 29
Molecular determinants of response of tumor cells to berberine
Efferth, T., Chen, Z., Kaina, B., & Gan, W. (2005) · Cancer Genomics & Proteomics · Cited by 20
Self-citationMoore, J. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03999-d · Cited by 20
Microarray-based Prediction of Cytotoxicity of Tumor Cells to Arsenic Trioxide.
Efferth, T., & Kaina, B. (2004) · PubMed · Cited by 16
Self-citation
Cited by
Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
Corson, T. W., & Crews, C. M. (2007) · Cell · doi:10.1016/j.cell.2007.08.021 · Cited by 654
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
Efferth, T. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.009 · Cited by 632
Self-citationWhat made sesquiterpene lactones reach cancer clinical trials?
Ghantous, A., Gali-Muhtasib, H., Vuorela, H., Saliba, N. A., & Darwiche, N. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.06.002 · Cited by 615
The Molecular Mechanism of Action of Artemisinin—The Debate Continues
O’Neill, P. M., Barton, V. E., & Ward, S. A. (2010) · Molecules · doi:10.3390/molecules15031705 · Cited by 595
From traditional Chinese medicine to rational cancer therapy
Efferth, T., Li, P. C. H., Konkimalla, V. S. B., & Kaina, B. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.07.001 · Cited by 528
Self-citation
Metadata
- Authors
- Efferth, T.
- Venue
- Planta Medica
- Publisher
- Georg Thieme Verlag KG
- Published
- 2007-04
- Volume
- 73
- Issue
- 4
- Pages
- 299-309
- ISSN
- 0032-0943 (ISSN-L)
- 1439-0221
- OpenAlex
- W2095518262
- Cited by
- 269
- References
- 91
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.